Close Menu

Ohio State

The collaborators will study the use of genomic medicine, genetic counseling, and electronic medical records for heart disease and hypertension.

By sequencing cDNA libraries derived from pesticide-sensitive and -resistant bed bugs, Ohio State University researchers have catalogued thousands of potential expressed sequence tags in the insect — and tracked down expression differences that they believe may be related to insecticide susceptibility.

Over the next five years, researchers from Ohio State University and Indiana University will study epigenetic changes in prostate, breast, and ovarian cancer cells that cause resistance to hormonal therapy or traditional chemotherapy.

Using expression data on thousands of human cancer and normal samples, researchers have identified tissue- and cancer-specific networks of genetically interacting miRNAs.

Researchers from the University Health Network in Toronto, the Mayo Clinic, Ohio State University, and University of Miami School of Medicine are among the early-access customers who have been using the product ahead of its commercial launch this week.

At the conference, Hood discussed family sequencing efforts at his lab and announced a partnership with OSU to advance “killer applications” for personalized medicine through industry/academia partnerships.

$50 million of the funding goes to two sequencing centers, split equally between the University of Washington in Seattle and the Broad Institute.

Ohio State will enroll 2,000 participants in Coriell's multi-center study.

OSU Medical Center will enroll patients who agree to join Coriell's personalized medicine project under the guidance of their primary care physician. The partners will study the impact of using genomic information in treating chronic conditions.

Using a mass spectrometry-based approach, researchers from Ohio State University performed a functional proteomics analysis that provides the most complete picture yet of the mechanisms involved in beef tenderness and that may eventually lead to a more precise method for predicting tenderness.


The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.